American Journal of Ophthalmology Case Reports · 2020 · 25 citations · 20 references
MedicineNeurologyOphthalmologyNeuro-ophthalmologyOcular DiseasePain ManagementBotulinum Toxin TherapyBotulinum Toxin TreatmentDry Eye DiseaseDry Eye EvaluationHeadache DisordersMigraine PharmacotherapyDry Eye AssessmentDry Eye SymptomatologyDry Eye TherapeuticsNeuropathic Ocular PainNeurotoxin InjectionsOcular Surface EffectsOcular SymptomsVisual Discomfort
PURPOSE: Individuals receiving botulinum toxin A (BoNT-A) injections in the head and neck for migraine treatment have reported decreases in photophobia and sensations of dryness, independent of ocular surface parameters. We hypothesized that patients without migraine but with similar ocular neuropathic-like symptoms would also experience symptomatic improvement with periocular BoNT-A injections, independent of ocular surface changes. OBSERVATIONS: We identified four individuals without a history of migraine but with neuropathic ocular pain (symptoms of dryness, burning, and photophobia that were out of proportion to ocular surface findings and unresponsive to ongoing dry eye (DE) therapies). Individuals underwent 1 session of periocular BoNT-A injections. Validated questionnaires (Visual Light Sensitivity Questionnaire-8, Dry Eye Questionnaire-5) assessed photophobia and DE symptoms pre- and 1-month post-injections. All four reported improvements in frequency and severity of photophobia and eye discomfort following BoNT-A injections. Tear film parameters (phenol red thread test, tear break-up time, corneal staining, and Schirmer test) and eyelid (palpebral fissure height and levator palpebrae superioris function) and eyebrow (position) anatomy were also evaluated before and after injections. Despite a unanimous improvement in symptoms, there were no consistent changes in ocular surface parameters with BoNT-A injections across individuals. CONCLUSIONS: Periocular BoNT-A shows promise in reducing photophobia and sensations of dryness in individuals with neuropathic-like DE symptoms without a history of migraine, independent of tear film, eyelid, or eyebrow parameters.
20
David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 986 citations
Robin L. Chalmers, Carolyn G. Begley, Barbara Caffery · Contact Lens and Anterior Eye · 2010 · 395 citations
Botulinum Toxin: Mechanism of Presynaptic Blockade
Ing Kao, Daniel B. Drachman, Donald L. Price · Science · 1976 · 271 citations
Shruti Aggarwal, Ahmad Kheirkhah, Bernardo M. Cavalcanti et al. · The Ocular Surface · 2015 · 143 citations · Full text